Cargando…

OX40L–OX40 Signaling in Atopic Dermatitis

OX40 is one of the co-stimulatory molecules expressed on T cells, and it is engaged by OX40L, primarily expressed on professional antigen-presenting cells such as dendritic cells. The OX40L–OX40 axis is involved in the sustained activation and expansion of effector T and effector memory T cells, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Furue, Masutaka, Furue, Mihoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230615/
https://www.ncbi.nlm.nih.gov/pubmed/34208041
http://dx.doi.org/10.3390/jcm10122578
_version_ 1783713252561125376
author Furue, Masutaka
Furue, Mihoko
author_facet Furue, Masutaka
Furue, Mihoko
author_sort Furue, Masutaka
collection PubMed
description OX40 is one of the co-stimulatory molecules expressed on T cells, and it is engaged by OX40L, primarily expressed on professional antigen-presenting cells such as dendritic cells. The OX40L–OX40 axis is involved in the sustained activation and expansion of effector T and effector memory T cells, but it is not active in naïve and resting memory T cells. Ligation of OX40 by OX40L accelerates both T helper 1 (Th1) and T helper 2 (Th2) effector cell differentiation. Recent therapeutic success in clinical trials highlights the importance of the OX40L–OX40 axis as a promising target for the treatment of atopic dermatitis.
format Online
Article
Text
id pubmed-8230615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82306152021-06-26 OX40L–OX40 Signaling in Atopic Dermatitis Furue, Masutaka Furue, Mihoko J Clin Med Commentary OX40 is one of the co-stimulatory molecules expressed on T cells, and it is engaged by OX40L, primarily expressed on professional antigen-presenting cells such as dendritic cells. The OX40L–OX40 axis is involved in the sustained activation and expansion of effector T and effector memory T cells, but it is not active in naïve and resting memory T cells. Ligation of OX40 by OX40L accelerates both T helper 1 (Th1) and T helper 2 (Th2) effector cell differentiation. Recent therapeutic success in clinical trials highlights the importance of the OX40L–OX40 axis as a promising target for the treatment of atopic dermatitis. MDPI 2021-06-11 /pmc/articles/PMC8230615/ /pubmed/34208041 http://dx.doi.org/10.3390/jcm10122578 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Furue, Masutaka
Furue, Mihoko
OX40L–OX40 Signaling in Atopic Dermatitis
title OX40L–OX40 Signaling in Atopic Dermatitis
title_full OX40L–OX40 Signaling in Atopic Dermatitis
title_fullStr OX40L–OX40 Signaling in Atopic Dermatitis
title_full_unstemmed OX40L–OX40 Signaling in Atopic Dermatitis
title_short OX40L–OX40 Signaling in Atopic Dermatitis
title_sort ox40l–ox40 signaling in atopic dermatitis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230615/
https://www.ncbi.nlm.nih.gov/pubmed/34208041
http://dx.doi.org/10.3390/jcm10122578
work_keys_str_mv AT furuemasutaka ox40lox40signalinginatopicdermatitis
AT furuemihoko ox40lox40signalinginatopicdermatitis